The CLAIMS consortium convened its 4th General Assembly (GA) on November 12, 2025, in the scenic town of Baveno, Italy. The event was a hybrid meeting, combining the face-to-face gathering in Baveno with online attendance, bringing together partners united by one mission: accelerating AI-enabled innovations for multiple sclerosis (MS) care. The meeting included dynamic updates […]
As we dive into the second half of 2025, we are excited to share the collective progress made by the CLAIMS consortium in the RECLAIM clinical study (NCT06280755). One of the key milestones we are proud to announce is the peer-reviewed publication of the RECLAIM study protocol: https://doi.org/10.3389/fneur.2025.1557947 RECLAIM STUDY PROTOCOL PUBLICATION About the Study
RECLAIM study protocol is published – cohort update Read More »
A primary objective of CLAIMS is to develop tools that enhance the monitoring of disease progression in patients with Multiple Sclerosis. In this regard, the team working on Work Package 4 aims to develop, validate, and implement novel MRI image analysis pipelines to more effectively distinguish between active inflammation and smouldering pathology in Multiple Sclerosis
Quantifying smouldering pathology – One scan at a time Read More »
As we close out 2024, we are proud to reflect on the significant progress we have made over the past year with the RECLAIM study. We now have longitudinal data from over 900 patients, including more than 13,000 MRI scans, all of which have been quantitatively analysed. RECLAIM (NCT06280755) aims to improve the care and
Milestones of the RECLAIM Study – Over 900 Patients and 13,000 MRI Scans Read More »
A future of AI-driven personalized care for people with multiple sclerosis We’ve published a new paper on the development of our icognition cognitive test battery! The full paper can be accessed here or via our Zenodo Repository. Abstract: Multiple sclerosis (MS) is a devastating immune-mediated disorder of the central nervous system resulting in progressive disability
New Paper published! Read More »
This project is supported by the Innovative Health Initiative Joint Undertaking (JU) under grant agreement No 101112153. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, EuropaBio, MedTech Europe, Vaccines Europe, AB Science SA and Icometrix NV.
Copyright. Claims 2024.